Biopharmaceutical company ATAI Life Sciences plans to make an initial investment of 5 million dollars to purchase Bitcoin

ChainCatcher news, according to CoinDesk, the biopharmaceutical public company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy, planning to initially invest $5 million to purchase Bitcoin. Following this news, ATAI's stock price briefly rose.

The company's chairman, Christian Angermayer, stated that the company plans to initially invest $5 million to purchase Bitcoin while retaining sufficient cash, short-term securities, and public equity to ensure the company's operating funds until 2027.